Ronald W. Dollens recently from the positions of CEO and President of Guidant Corp., Indianapolis, a medical device manufacturer in retirement. Dollens was appointed CEO and President of Guidant, when the company was founded as a split-off from Eli Lilly and Co. in 1994. During his 10 years at Guidant’s leadership the company grew by an average of 18% per year, from nearly 900 million in sales in 1994 to $ 3.7 billion in 2003. Guidant today employs more than 12,000 and is an industry leader … Read more »

Ronald W. Dollens recently from the positions of CEO and President of Guidant Corp., Indianapolis, a medical device manufacturer in retirement. Dollens was appointed CEO and President of Guidant, when the company was founded as a split-off from Eli Lilly and Co. in 1994. During his 10 years at Guidant’s leadership the company grew by an average of 18% per year, from nearly 900 million in sales in 1994 to $ 3.7 billion in 2003. Guidant today employs more than 12,000 and is an industry leader in the field of cardiovascular technology.
«Hide

from
Catherine M. Dalton
Source: Business Horizons
11 pages.
Release Date: 15, March 2005. Prod #: BH115-PDF-ENG
Leadership, direction and performance at Guidant Corp.: An Interview with Ronald W. Dollens HBR case solution